You would think so, but I imagine the DOCA approval is to be based on the reports already presented by Woods et al. The ad hoc committee proposed the DOCA and Woods's reports seem to be based around supporting their case. It is laughable that he had a meeting with them to convince them to accept their own proposal. Woods has also indicated that any other submissions to the court should be submitted through KPMG. Why shouldn't they be submitted independently?
- Forums
- ASX - By Stock
- PDN
- Ann: Financial Reporting Relief
Ann: Financial Reporting Relief, page-5
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PDN (ASX) to my watchlist
|
|||||
Last
$13.79 |
Change
-0.190(1.36%) |
Mkt cap ! $4.109B |
Open | High | Low | Value | Volume |
$13.78 | $13.88 | $13.62 | $17.15M | 1.248M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 1426 | $13.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.79 | 1352 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 1487 | 13.770 |
12 | 3038 | 13.760 |
14 | 3967 | 13.750 |
9 | 3602 | 13.740 |
11 | 5991 | 13.730 |
Price($) | Vol. | No. |
---|---|---|
13.780 | 2680 | 21 |
13.790 | 3331 | 15 |
13.800 | 5982 | 15 |
13.810 | 8279 | 13 |
13.820 | 2364 | 9 |
Last trade - 12.51pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
PDN (ASX) Chart |